Related Experiment Video
Updated: Sep 21, 2025
07:25
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
3.1K
Sjögren syndrome: looking forward to the future.
Sara Zandonella Callegher1, Ivan Giovannini2, Sabine Zenz3
1Department of Rheumatology, Hospital of Bruneck, Bruneck, Italy.
Therapeutic Advances in Musculoskeletal Disease
|May 31, 2022
Summary
Recent advances in primary Sjögren
Area of Science:
- Rheumatology, Immunology, and Autoimmune Diseases
Background:
- Primary Sjögren's syndrome (pSS) is a complex autoimmune disease with diverse patient manifestations.
- Understanding pSS progression from early stages to established disease is crucial for effective management.
Purpose of the Study:
- To review recent advancements in the diagnosis, prognosis, and management of primary Sjögren's syndrome.
- To explore future clinical and research directions for pSS.
Main Methods:
- Qualitative literature review analyzing diagnostic, prognostic, and management aspects of pSS.
- Focus on early disease phases, diagnostic innovations, and patient stratification strategies.
Main Results:
- Salivary gland ultrasound (SGUS) shows promise as a diagnostic tool, potentially complementing or replacing histopathology.
- Innovations include AI in SGUS, ultrasound-guided biopsy, and novel biomarkers for diagnosis and prognosis.
- Patient stratification using integrated data is key for personalized treatment and lymphoma risk assessment.
Conclusions:
- pSS management requires considering disease heterogeneity across stages and patient subsets.
- Emerging diagnostic and therapeutic strategies are poised to enhance clinical practice and patient outcomes.
- Further research into treatment response evaluation is needed for optimizing individualized care.
Keywords:
Sjögren’s syndromeactivitybiomarkersdamagehistopathologylymphomapathogenesispreclinical phasesalivary glandtreatmentultrasonographyMore Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
546
09:42A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
Published on: June 7, 2017
11.6K
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
29
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
29
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:24Nephrotic Syndrome I : Introduction
41
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
41
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:29Autoimmune Disorders
688
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
688
01:20Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K